FOXO Technologies (FOXO) Company Sales Volume

FOXO Technologies is implementing epigenetic AI into the insurance sector for personalized longevity analysis. Cloud infrastructure in the US minimizes technical failures and operational risks. The licensing of DNA tests ensures a steady cash flow. The company's commercial sales volume demonstrates market resilience, where the 0.01 indicator determines the status of the current revenue parameter.

FOXO FOXO Technologies, Inc.: Company Revenue in the range 04/28/2023 - 08/24/2025

Comprehensive metric breakdowns and analytics for FOXO Technologies Inc. (FOXO)

- share price and expert price forecast:

Price Performance Chart foxotechnologies.com|FOXO - Price Target Chart

- market capitalization details:

Market Capitalization FOXO Technologies Inc.|FOXO - Total Company Value

- issuer book value statistics:

Net Asset Value per Share FOXO Technologies|FOXO - Company Book Value|Market Value to Book Value Ratio foxotechnologies.com|FOXO - Aggregate Company Assets

- company liabilities and liquidity data:

- business earnings and investment ratios data:

FOXO - Net Profit|Forward Earnings FOXO Technologies|FOXO - Price to Earnings Ratio|Projected Price to Earnings Ratio foxotechnologies.com|FOXO - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation FOXO Technologies Inc.|FOXO - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months FOXO Technologies|FOXO - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth foxotechnologies.com|FOXO - Earnings growth in current year|Consensus forecast of earnings per share growth for next year FOXO Technologies

- sales volume and revenue indicators:

FOXO - Revenue and Sales Volume|Company Expected Revenue FOXO Technologies, Inc.|FOXO - Price-to-Revenue Ratio|Market Cap to Future Revenue Ratio FOXO Technologies Inc.

Summary company analysis:FOXO Technologies

Investors assess operational strength via daily sales volume, where the company's trading revenue captures fundamental business shifts and the risk of overpaying for an overheated asset. For FOXO Technologies (FOXO), this indicator reflects the monetization efficiency of AI underwriting algorithms and epigenetic analysis in partnership with longevity laboratories, confirming the resilience of digital synergy within the insurance sector.

Key competitors